In summary, we present compelling evidence that HIF1-mediated pseudohypoxic conditions are genetically selected in PCC via the disruption of multiple VHL complex components and we provide further rationale for exploring this pathway as a therapeutic target in PCC with potential application to RCC and other VHL-related diseases. Here, VHL is linked to renal cell carcinoma.